Free Access
Review
Table I.
The emergence of specific mutations in the genome of CPV that became widespread during the evolution of the virus in dogs.
Mutation(s) that have become widespread | Mutant virus name (if any) | Year of first recognition (approximate in some cases) | Relative prevalence |
---|---|---|---|
VP2 residues | FPV to CPV | Associated with the host range switch from cats to dogs. Result in altered binding to the canine transferrin receptor. | |
80 Arg to Lys | |||
93 Lys to Asn | |||
103 Val to Ala | |||
323 Asp to Asn | |||
564 Asn to Ser | |||
568 Ala to Gly | |||
VP2 residues | CPV-2a | 1979 | 100% by ~ 1980 |
87 Met to Leu | |||
101 Ile to Thr | |||
300 Ala to Gly | |||
305 Asp to Tyr | |||
VP2 residue 426 Asn to Asp | CPV-2b | 1984 | 30–80% between 1984 and 2005 |
VP2 residue 297 Ser to Ala | 1990 | Increasing to > 90% by 2000 | |
VP2 residue 426 Asp to Glu | CPV-2c | 2001 | Increasing after 2001, becoming globally distributed; no estimate available |
VP2 residue 440, Thr to Ala | ~ 2005 | Found in several countries around world, no estimate available |